Daniel M. Green, MD

Daniel M. Green, MD

Member, St. Jude Faculty

Departments

Epidemiology and Cancer Control
Oncology

Divisions

Cancer Survivorship

Contact Information

Daniel M. Green, MD
Epidemiology and Cancer Control
MS 735
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: daniel.green@stjude.org
Phone: (901) 595-5915
FAX: (901) 595-5845

Education

BS - Massachusetts Institute of Technology Cambridge, Massachusetts (1969)
MD - St. Louis University School of Medicine, St. Louis, Missouri (1973)


Research Interests


Current Research

CCSS, Co-Investigator
SJLIFE, Study Committee
St. Jude Consortium for Interventional Research, Chairman


Selected Publications

Smith WA, Ness KK, Joshi V, Hudson MM, Robison LL, Green DM. Exercise training in childhood cancer survivors with subclinical cardiomyopathy who were treated with anthracyclines. Pediatr Blood Cancer 2014 (in press).

Huang TT, Chen Y, Dietz AC, Yasui Y, Donaldson SS, Stokes DC, Leisenring WM, Sklar CA, Diller LR, Mertens AC, Armstrong GT, Green DM, Robison LL, Ness KK. Pulmonary outcomes in survivors of childhood central nervous system malignancies: A Report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 61:319–325, 2014.

Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava DK, Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, Diller LR, Stovall M, Donaldson SS, Robison LL. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure. A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 61:53–67, 2014.

Green DM, Kun LE, Matthay KK, Meadows AT, Meyer WH, Meyers PA, Spunt SL, Robison LL, Hudson MM. Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors. Pediatr Blood Cancer 60:1083-1094, 2013.

Ojha R, Gurney J, Green DM. Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors – Ready for prime time? Pediatr Blood Cancer 60:1245-1246, 2013

Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KK, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309:2371-2381, 2013.

Kieran K, Anderson JR, Dome JS, Ehrlich PF, Ritchey ML, Shamberger RC, Perlman EJ, Green DM, Davidoff AM. Is adrenalectomy necessary during unilateral nephrectomy for Wilms tumor? A report from the Children's Oncology Group. J Pediatr Surg 48:1598–1603, 2013.

Green DM, Lange JM, Qu A, Peterson SM, Kalapurakal JA, Stokes DC, Grigoriev YA, Takashima JR, Norkool P, Friedman DL, Breslow NE. Pulmonary disease after treatment for Wilms tumor: A report from the National Wilms Tumor Long-Term Follow-Up Study. Pediatr Blood Cancer 60:1721–1726, 2013

Brinkman TM, Ullrich NJ, Zhang N, Green DM, Zeltzer LK, Lommel KM, Brouwers P, Srivastava DK, Jain N, Robison LL, Krull KR. Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Cancer Surviv 7:104-14, 2013.

Green DM. Evaluation of renal function after successful treatment for unilateral, non-syndromic Wilms tumor. Pediatr Blood Cancer 60:1929-1935, 2013.

Klosky JL , Russell KM, Canavera KE, Gammel HL, Hodges JR, Foster RH, Parra GR, Simmons JL, Green DM, Hudson MM. Risk factors for non-initiation of the human papillomavirus (HPV) vaccine among adolescent survivors of childhood cancer. Cancer Prevention Research 6:1101-1110, 2013.

Ness KK, Krull KK, Jones KE, Mulrooney DA, Armstrong GT, Green DM, ChemaitillyW, Smith WA, Wilson CL, Sklar CA, Shelton K, Srivastava DK, Ali S, Robison LL, Hudson MM. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A Report from the St. Jude Lifetime Cohort Study. J Clin Oncol 31:4496-4503, 2013.

Green DM, Zhu L, Zhang N, Sklar CA, Ke RW, Kutteh WH, Klosky JL, Spunt SS, Metzger ML, Navid F, Srivastava D, Robison LL, Hudson MM. The utility of plasma concentrations of inhibin B and follicle stimulating hormone for identification of azoospermic survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study. J Clin Oncol 31:1324-1328, 2013.

Metzger ML, Meacham L, Patterson B, Casillas JS, Constine LS, Hijiya N, Kenney LB, Leonard M, Lockart BA, Likes W, Green DM. Female reproductive health after childhood, adolescent and young adult cancer: guidelines for the assessment, and management of female reproductive complications. J Clin Oncol 31:1239-1247, 2013.

Armstrong GT, Joshi VM, Zhu L, Srivastava D, Zhang N, Ness KK, Stokes DC, Krasin MT, Fowler JA, Robison LL, Hudson MM, Green DM. Elevated tricuspid regurgitant jet velocity by Doppler echocardiography in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study. J Clin Oncol 31:774-781, 2013.

Green DM. Robert E. Gross Lecture - The evolution of treatment for Wilms tumor. J Pediatr Surg 48:14-19, 2013.

Krull KR, Sabin ND, Reddick WE, Zhu L, Armstrong GT, Green DM, Arevalo AR, Krasin MJ, Srivastava DK, Robison LL, Hudson MM. Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin lymphoma. J Clin Oncol 30:3618-24, 2012.

Kenney LB, Cohen LE, Shnorhavorian M, Metzger M, Lockhart B, Hijiya N, Duffey-Lind E, Constine L, Green D, Meacham L. Male reproductive health after childhood, adolescent, and young adult cancer: a report from the Children's Oncology Group. J Clin Oncol 30:3408-3416, 2012. PMCID: PMC3438236

Motosue MM, Zhu L, Srivastava K, Stokes DC, Hudson MM, McPherson V, Srinivasan S, Krasin MJ, Green DM, Spunt SK, Inaba H. Pulmonary function after whole lung irradiation in pediatric patients with solid malignancies. Cancer 118:1450-1456, 2012. PMCID: PMC3233655

Green DM, Cox CL, Zhu L, Srivastava DK, Stovall M, Nolan VG, Ness KK, Donaldson SS, Oeffinger KC, Meacham LR, Sklar CA, Krull KR, Armstrong GT, Robison LL. Risk factors for obesity in adult survivors of childhood cancer. A report from the Childhood Cancer Survivor Study. J Clin Oncol 30:246-255, 2012. PMCID: PMC3269951

Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, Mertens AC, Whitton JA, Robison LL, Boice JD Jr. Congenital anomalies in the children of cancer survivors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 30:239-245, 2012. PMCID: PMC3008402

Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Srivastava D, Leisenring W, Robison LL, Sklar CA. Decreased risk of pregnancy among female childhood cancer survivors who received 22 to 27 Gy hypothalamic/pituitary irradiation. A report from the Childhood Cancer Survivor Study. Fertil Steril 95:1922-1927, 2011. PMCID: PMC3080448

Hudson MM, Ness KK, Nolan VG, Armstrong GT, Green DM, Morris EB, Spunt SS, Metzger ML, Krull KK, Klosky J, Srivastava DK, Robison LL. Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 56:825-836, 2011. PMCID: PMC3088729

Other publications

Last updated: February 2014